دورية أكاديمية
أعرض في EDS

Immunomodulation of Homeopathic Thymulin 5CH in a BCG-Induced Granuloma Model.

التفاصيل البيبلوغرافية
العنوان: Immunomodulation of Homeopathic Thymulin 5CH in a BCG-Induced Granuloma Model.
المؤلفون: Bonamin LV; Research Center of Universidade Paulista, Rua Dr. Bacelar 1212, 5th Floor, 04026-002 São Paulo, SP, Brazil ; Laboratory of Veterinary Pathology, Universidade de Santo Amaro, São Paulo, SP, Brazil ; Instituto de Ensino, Pesquisa e Desenvolvimento Royal, São Roque, SP, Brazil., Sato C, Zalla Neto R, Morante G, Cardoso TN, de Santana FR, Coelho Cde P, Osugui L, Popi AF, Hurtado EC, Mariano M
المصدر: Evidence-based complementary and alternative medicine : eCAM [Evid Based Complement Alternat Med] 2013; Vol. 2013, pp. 686018. Date of Electronic Publication: 2013 Jan 28.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Hindawi Pub Country of Publication: United States NLM ID: 101215021 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1741-427X (Print) Linking ISSN: 1741427X NLM ISO Abbreviation: Evid Based Complement Alternat Med Subsets: PubMed not MEDLINE
أسماء مطبوعة: Publication: 2011- : New York, NY : Hindawi Pub.
Original Publication: Oxford, UK : Oxford University Press, c2004-
مستخلص: The present study analyzed the immune modulation mechanisms of thymulin 5CH in a granuloma experimental model. Male adult Balb/c mice were inoculated with BCG into the footpad to induce granuloma, which was quantitatively evaluated. The phenotypic characterization of phagocyte, T- and B-lymphocyte populations in the peritoneum, and local lymph node was done by flow cytometry. During all experimental periods, thymulin 5CH and vehicle (control) were given ad libitum to mice, diluted into the drinking water (1.6 × 10(-17) M). After 7 days from inoculation, thymulin-treated mice presented reduction in the number of epithelioid cytokeratine-positive cells (P = 0.0001) in the lesion, in relation to young phagocytes. After 21 days, the differentiation of B1 peritoneal stem cells into phagocytes reached the peak, being higher in thymulin-treated mice (P = 0.0001). Simultaneously, the score of infected phagocytes in the lesion decreased (P = 0.001), and the number of B1-derived phagocytes, CD4+ and CD8+ T lymphocytes in the local lymph node increased in relation to control (P = 0.0001). No difference was seen on the CD25+ Treg cells. The results show that thymulin 5CH treatment is able to improve the granuloma inflammatory process and the infection remission, by modulating local and systemic phagocyte differentiation.
References: J Immunol. 1999 Oct 1;163(7):3605-11. (PMID: 10490953)
J Pineal Res. 1996 Aug;21(1):35-43. (PMID: 8836962)
Immunobiology. 2010 Mar;215(3):215-22. (PMID: 19457571)
J Korean Med Sci. 2012 Jan;27(1):27-35. (PMID: 22219610)
Homeopathy. 2011 Oct;100(4):220-7. (PMID: 21962196)
Immunobiology. 2010 Dec;215(12):1005-14. (PMID: 20188435)
C R Seances Acad Sci III. 1982 Oct 4;295(4):283-6. (PMID: 6817864)
Immunology. 2009 Jan;126(1):114-22. (PMID: 18710404)
Immunol Today. 1985 Aug;6(8):234-5. (PMID: 25290364)
Homeopathy. 2012 Jan;101(1):68-73. (PMID: 22226317)
Ann N Y Acad Sci. 2009 Sep;1173:280-5. (PMID: 19758163)
Acta Neurol Scand. 1986 Apr;73(4):338-44. (PMID: 3727911)
Evid Based Complement Alternat Med. 2006 Dec;3(4):397-409. (PMID: 17173103)
Evid Based Complement Alternat Med. 2005 Dec;2(4):441-52. (PMID: 16322800)
J Rheumatol. 1997 Aug;24(8):1564-9. (PMID: 9263152)
Immunol Rev. 1986 Oct;93:81-102. (PMID: 3096879)
Evid Based Complement Alternat Med. 2006 Mar;3(1):13-24. (PMID: 16550219)
Immunobiology. 2010 Apr;215(4):264-74. (PMID: 19581018)
Immunol Today. 1996 Oct;17(10):471-5. (PMID: 8908812)
Homeopathy. 2009 Oct;98(4):280-6. (PMID: 19945680)
Homeopathy. 2010 Oct;99(4):231-42. (PMID: 20970092)
Nat Rev Immunol. 2011 Jan;11(1):34-46. (PMID: 21151033)
Immunity. 2005 Jul;23(1):7-18. (PMID: 16039575)
Glycobiology. 2009 Nov;19(11):1248-58. (PMID: 19696234)
Microbiol Immunol. 2004;48(9):629-38. (PMID: 15383698)
Cell Immunol. 1996 Jul 10;171(1):30-40. (PMID: 8660834)
Mol Immunol. 2009 May;46(8-9):1613-9. (PMID: 19327839)
Homeopathy. 2010 Jan;99(1):37-50. (PMID: 20129175)
J Gerontol A Biol Sci Med Sci. 2000 Apr;55(4):B170-6. (PMID: 10811143)
J Immunol. 1995 Nov 1;155(9):4155-61. (PMID: 7594570)
J Immunol. 2000 Nov 15;165(10):5518-29. (PMID: 11067905)
PLoS One. 2012;7(3):e34143. (PMID: 22479545)
Homeopathy. 2010 Jan;99(1):25-36. (PMID: 20129174)
Immunology. 2004 Nov;113(3):348-54. (PMID: 15500621)
J Immunol. 2003 Nov 15;171(10):5406-14. (PMID: 14607944)
G Ital Med Lav Ergon. 2005 Jul-Sep;27(3):335-8. (PMID: 16240589)
Ann N Y Acad Sci. 2009 Feb;1153:98-106. (PMID: 19236333)
Immunobiology. 2009;214(8):664-73. (PMID: 19321225)
Br Homeopath J. 2001 Oct;90(4):198-203. (PMID: 11680804)
Evid Based Complement Alternat Med. 2006 Jun;3(2):171-86. (PMID: 16786046)
Homeopathy. 2008 Oct;97(4):202-5. (PMID: 19371569)
Experientia. 1990 May 15;46(5):484-6. (PMID: 2189748)
Microbes Infect. 2006 Mar;8(3):589-97. (PMID: 16500129)
Radiat Res. 1992 Mar;129(3):351-6. (PMID: 1542723)
Homeopathy. 2004 Oct;93(4):193-8. (PMID: 15532698)
J Immunol. 2005 Dec 1;175(11):7170-8. (PMID: 16301620)
PLoS One. 2012;7(3):e33955. (PMID: 22448280)
PLoS One. 2012;7(3):e34570. (PMID: 22479646)
Ann N Y Acad Sci. 1975 Feb 28;249:186-210. (PMID: 1079427)
Biomed Pharmacother. 1988;42(3):197-206. (PMID: 3263148)
J Exp Med. 2006 Oct 30;203(11):2541-50. (PMID: 17060475)
Eur J Immunol. 1992 Mar;22(3):711-7. (PMID: 1547817)
Int Immunol. 2001 Sep;13(9):1193-201. (PMID: 11526100)
BMC Complement Altern Med. 2007 Jan 17;7:1. (PMID: 17233886)
Evid Based Complement Alternat Med. 2012;2012:710923. (PMID: 22899956)
Ann N Y Acad Sci. 2006 Nov;1088:153-63. (PMID: 17192563)
Evid Based Complement Alternat Med. 2011;2011:917541. (PMID: 21318109)
BMC Complement Altern Med. 2012 Oct 22;12:191. (PMID: 23088629)
Homeopathy. 2009 Oct;98(4):267-79. (PMID: 19945679)
Ann Med. 1999 Oct;31 Suppl 2:34-9. (PMID: 10574153)
J Vet Med Sci. 1995 Apr;57(2):307-10. (PMID: 7492651)
Evid Based Complement Alternat Med. 2007 Jun;4(2):149-63. (PMID: 17549232)
Biochem Biophys Res Commun. 2003 Nov 14;311(2):501-5. (PMID: 14592444)
تواريخ الأحداث: Date Created: 20130223 Date Completed: 20130225 Latest Revision: 20211021
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC3569925
DOI: 10.1155/2013/686018
PMID: 23431344
قاعدة البيانات: MEDLINE
الوصف
تدمد:1741-427X
DOI:10.1155/2013/686018